Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients  Linong Ji, MD, Dayi Hu, MD, Changyu Pan, MD,

Slides:



Advertisements
Similar presentations
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Advertisements

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study  Dr Jack R W Brownrigg,
High Positive End-Expiratory Pressure Is Associated with Improved Survival in Obese Patients with Acute Respiratory Distress Syndrome  Christian Bime,
The Epidemic of the 20th Century: Coronary Heart Disease
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease  Kentaro Kamiya, PT, PhD, Takashi Masuda, MD, PhD, Shinya Tanaka, PT, MSc, Nobuaki.
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,
Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease  Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.
Copyright © 2007 American Medical Association. All rights reserved.
Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization  Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,
The Effect of Smoking on the Risk of Sciatica: A Meta-analysis
Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity  Bjarne M. Nes, PhD, Christian R.
Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women  Xuemei Sui, MD, MPH, PhD, Mark A. Sarzynski,
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L
The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study  Ido Weinberg, Philimon Gona, Christopher.
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis  Islam Y. Elgendy,
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke  David Pereg, MD, Zach Rozenbaum, MD, Dina Vorobeichik, MA, Nir Shlomo,
The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure  Anna Gu, MD, PhD, Yu Yue, PhD, Joohae Kim, PharmD Candidate, Edgar.
Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008  Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Body Mass Index and Mortality in Acute Myocardial Infarction Patients
Volume 7, Issue 10, Pages (October 2010)
The Epidemic of the 20th Century: Coronary Heart Disease
Cardiovascular Disease and CKD: Core Curriculum 2010
Robert Goulden, MBBS, MSc, MPhil, MA  The American Journal of Medicine 
Sabina Hunziker, MD, MPH, Jennifer Stevens, MD, MS, Michael D
Age and Gender Differences in Quality of Care and Outcomes for Patients with ST- segment Elevation Myocardial Infarction  Sripal Bangalore, MD, MHA, Gregg.
CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation
Jessica L. Lee, MD, MS, Esther S. Oh, MD, Rebecca W. Lee, MD, Thomas E
TIA for the Internist The American Journal of Medicine
Hong-Tao Tie, MD, Rui Shi, MD  The American Journal of Medicine 
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials  Sripal Bangalore, MD, MHA, Bora Toklu,
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
Syncope: Outcomes and Conditions Associated with Hospitalization
Michael A. Weber, MD, George L
Personalized Activity Intelligence (PAI) for Prevention of Cardiovascular Disease and Promotion of Physical Activity  Bjarne M. Nes, PhD, Christian R.
Longitudinal Patterns of Cardiorespiratory Fitness Predict the Development of Hypertension Among Men and Women  Xuemei Sui, MD, MPH, PhD, Mark A. Sarzynski,
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Associations of Coffee, Tea, and Caffeine Intake with Coronary Artery Calcification and Cardiovascular Events  P. Elliott Miller, MD, Di Zhao, PhD, Alexis.
Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease  Jessica Kendrick,
Interaction of Physical Activity and Body Mass Index on Mortality in Coronary Heart Disease: Data from the Nord-Trøndelag Health Study  Trine Moholdt,
When Guidelines Cause Hypertension
Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease  Kentaro Kamiya, PT, PhD, Takashi Masuda, MD, PhD, Shinya Tanaka, PT, MSc, Nobuaki.
Molly E. Waring, PhD, Jane S
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy  Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.
Long-Term Use of Aspirin and the Risk of Gastrointestinal Bleeding
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
MATCH Results: Implications for the Internist
Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J
Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study  Anna Gu, MD, PhD, Yu Yue,
One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials  David S. Wald, MD, FRCP, Shahena Butt, MSc,
Sodium Intake and Mortality in the NHANES II Follow-up Study
Volume 73, Issue 8, Pages (April 2008)
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Alcohol Intake More than Doubles the Risk of Early Cardiovascular Events in Young Hypertensive Smokers  Paolo Palatini, MD, Claudio Fania, MD, Lucio Mos,
Volume 75, Issue 1, Pages (January 2009)
Temporal trends in the incidence of coronary disease
Baseline Q Waves and Time From Symptom Onset to ST-segment Elevation Myocardial Infarction: Insights From PLATO on the Influence of Sex  Naji Kholaif,
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength
Volume 95, Issue 6, Pages (June 2019)
Surgical decortication as the first-line treatment for pleural empyema
Paul D. Stein, MD, Fadi Matta, MD  The American Journal of Medicine 
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States  Ahmet Ergin, MD, PhD, MPH, Paul.
HR for mortality in ischemic heart disease.
HR for myocardial infarction.
Presentation transcript:

Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients  Linong Ji, MD, Dayi Hu, MD, Changyu Pan, MD, Jianping Weng, MD, Yong Huo, MD, Changsheng Ma, MD, Yiming Mu, MD, Chuanming Hao, MD, Qiuhe Ji, MD, Xingwu Ran, MD, Benli Su, MD, Hanjing Zhuo, MPH, Keith A.A. Fox, MD, Michael Weber, MD, Danyi Zhang, MD  The American Journal of Medicine  Volume 126, Issue 10, Pages 925.e11-925.e22 (October 2013) DOI: 10.1016/j.amjmed.2013.02.035 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Association of cardiovascular risk factors and comorbidity in patients with type 2 diabetes who participated in the 3B STUDY. Some patients had more than one comorbidity. BMI = body mass index; CBD = cerebrovascular disease (including ischemic stroke, hemorrhagic stroke or transient ischemic attack); CVD = cardiovascular disease (including stable angina, unstable angina, myocardial infarction, percutaneous coronary intervention, or underwent coronary bypass); T2D = type 2 diabetes; T2D+DYLP = type 2 diabetes with comorbid dyslipidemia; T2D+HTN = type 2 diabetes with comorbid hypertension; T2D+HTN+DYLP = type 2 diabetes with both comorbid hypertension and dyslipidemia. The American Journal of Medicine 2013 126, 925.e11-925.e22DOI: (10.1016/j.amjmed.2013.02.035) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Independent factors that may predict or influence the control of cardiovascular risk factors (HbA1c <7.0%, TC <4.5 mmol/L, and BP <130/80 mm Hg) in patients with Type 2 diabetes who participated in the 3B STUDY. (A) Independent predictors for HbA1c <7.0%. (B) Independent predictors for HbA1c <7.0% and BP <130/80 mm Hg. (C) Independent predictors for HbA1c <7.0% and TC <4.5 mmol/L. (D) Independent predictors for all targets (HbA1c <7.0%, TC <4.5 mmol/L, and BP <130/80 mm Hg) met.Abbreviations: BP = blood pressure; CI = confidence interval; HbA1c = glycosylated hemoglobin; OR = odds ratio; TC = total serum cholesterol. Adjusted OR with their 95% CIs are reported from the final models. Variables in the full multivariate model for each dependent variable included: age, sex, body mass index, education level, medical insurance, personal income, smoking, alcohol consumption, physical activities, duration of diabetes, hospital tier, and physician specialty. Age, body mass index, and diabetes are converted to categorical variables. The American Journal of Medicine 2013 126, 925.e11-925.e22DOI: (10.1016/j.amjmed.2013.02.035) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 Independent factors that may predict or influence the control of cardiovascular risk factors (HbA1c <7.0%, TC <4.5 mmol/L, and BP <130/80 mm Hg) in patients with Type 2 diabetes who participated in the 3B STUDY. (A) Independent predictors for HbA1c <7.0%. (B) Independent predictors for HbA1c <7.0% and BP <130/80 mm Hg. (C) Independent predictors for HbA1c <7.0% and TC <4.5 mmol/L. (D) Independent predictors for all targets (HbA1c <7.0%, TC <4.5 mmol/L, and BP <130/80 mm Hg) met.Abbreviations: BP = blood pressure; CI = confidence interval; HbA1c = glycosylated hemoglobin; OR = odds ratio; TC = total serum cholesterol. Adjusted OR with their 95% CIs are reported from the final models. Variables in the full multivariate model for each dependent variable included: age, sex, body mass index, education level, medical insurance, personal income, smoking, alcohol consumption, physical activities, duration of diabetes, hospital tier, and physician specialty. Age, body mass index, and diabetes are converted to categorical variables. The American Journal of Medicine 2013 126, 925.e11-925.e22DOI: (10.1016/j.amjmed.2013.02.035) Copyright © 2013 Elsevier Inc. Terms and Conditions